Abstract Previous studies have indicated that the early steps in the isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes. However, the role of peroxisomes in cholesterol biosynthesis has recently been questioned in several reports concluding that three of the peroxisomal cholesterol biosynthetic enzymes, namely mevalonate kinase, phosphomevalonate kinase, and mevalonate diphosphate decarboxylase, do not localize to peroxisomes in human cells even though they contain consensus peroxisomal targeting signals. We re-investigated the subcellular localization of the cholesterol biosynthetic enzymes of the pre-squalene segment in human cells by using new stable isotopic techniques and data computations with isotopomer spectral analysis, in combination with immunoXuorescence and cell permeabilization techniques. Our present Wndings clearly show and conWrm previous studies that the pre-squalene segment of the cholesterol biosynthetic pathway is localized to peroxisomes. In addition, our data are consistent with the hypothesis that acetyl-CoA derived from peroxisomal -oxidation of very long-chain fatty acids and medium-chain dicarboxylic acids is preferentially channeled to cholesterol synthesis inside the peroxisomes without mixing with the cytosolic acetyl-CoA pool.
Introduction
Peroxisomes are ubiquitous and highly versatile organelles of eukaryotic cells whose enzymes participate in various metabolic pathways including: (1) -oxidation of a speciWc set of lipids which cannot be processed by mitochondria (very long-chain fatty acids, long-chain dicarboxylic acids, eicosanoids, and bile acid intermediates), (2) biosynthesis of cholesterol, isoprenoids, and ether-phospholipids (plasmalogens), and (3) reactive oxygen species metabolism Wanders 2004 ; Kovacs et al. 2002; Schrader and Fahimi 2004) . Two peroxisomal targeting signals (PTSs), PTS1 and PTS2, account for the transport of most enzymes involved in these metabolic pathways into the peroxisome matrix (Subramani 1993 ). PTS1, the major targeting signal, is a carboxyl-terminal tripeptide with the consensus sequence (S/C/A)(K/R/H)(L/M) and targets proteins to the peroxisome in all eukaryotic organisms examined, from yeast to man. PTS1-dependent transport is mediated by a shuttling receptor, the peroxin Pex5p, which recognizes the PTS1 tripeptide in the cytoplasm and mediates the import of PTS1-containing proteins into the peroxisome (Dammai and Subramani 2001) . Recent analysis of sequence variability in the PTS1 motif revealed that, in addition to the known C-terminal tripeptide, at least nine residues directly upstream are important for signal recognition in the PTS1-Pex5p receptor complex (Neuberger et al. 2003a ). The importance of speciWc residues near the C-terminus appears to be particularly important if the C-terminal tripeptide deviates from the conservative consensus PTS1 (Lametschwandtner et al. 1998) . A small subset of peroxisomal matrix proteins is targeted by PTS2, which consists of a degenerate nine-residue signal located internally or near the amino terminus. The consensus PTS2 has the sequence-(R/K)(L/V/I)X5(H/Q)(L/ A)- (Rachubinski and Subramani 1995) . Some PTS2 proteins have the PTS2 removed by a peroxisomal peptidase upon entering the peroxisomal lumen (Subramani 1993) . The import of PTS2 proteins into peroxisomes is mediated by the hydrophilic cytoplasmic receptor Pex7p, which is also dependent on the long isoform of Pex5p (Mukai et al. 2002; Ghys et al. 2002) .
Isoprenoids and isoprenoid compounds play vital roles in all living systems, e.g. in the structure of cells, in electron transport, in glycoprotein synthesis, in cell to cell signaling, in transfer RNAs, in the structure of organisms, and in the interactions between organisms (Goldstein and Brown 1990) . The enzymes that produce cholesterol and other isoprenoids are distributed in diVerent subcellular compartments (Kovacs et al. 2002) . The prevailing view has been that cholesterol biosynthetic reactions occur in the cytoplasm and endoplasmic reticulum (ER). However, numerous studies have indicated that the early steps in the isoprenoid/cholesterol biosynthetic pathway occur in peroxisomes (Keller et al. 1985 (Keller et al. , 1986 Stamellos et al. 1992; Biardi et al. 1994; Krisans et al. 1994; Biardi and Krisans 1996; Chambliss et al. 1996; Paton et al. 1997; Olivier et al. 1999 Olivier et al. , 2000 Gupta et al. 1999; Kovacs et al. 2001) . In addition, with the exception of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzymes contain functional PTSs (Table 1) . Furthermore, the enzymes catalyzing the conversion of mevalonate to farnesyl diphosphate (FPP) appear to be exclusively peroxisomal. Due to these facts, a new model for the compartmentation of the cholesterol biosynthetic pathway has been presented (Kovacs et al. 2002) .
However, the role of peroxisomes in cholesterol biosynthesis has recently been questioned in several reports concluding that three of the peroxisomal cholesterol biosynthetic enzymes, namely mevalonate kinase (MVK), phosphomevalonate kinase (PMVK), and mevalonate diphosphate decarboxylase (MPD), do not localize to peroxisomes in human cells even though they contain consensus PTSs (Hogenboom et al. 2004a, b, c) .
Since the data from Hogenboom et al. (2004a, b, c) are conXicting with the concept of a peroxisomal segment of cholesterol biosynthesis and our previous work was done mainly using rat liver and Chinese hamster ovary (CHO) cells, we decided to re-investigate the subcellular localization of the "pre-squalene" cholesterol biosynthetic enzymes in human cells. By using new stable isotopic techniques and data computations with isotopomer spectral analysis (ISA), in combination with immunoXuorescence and selective permeabilization techniques, we clearly conWrm our previous studies obtained in rats and CHO cells. In addition, we provide new evidence compatible with the presence of the presqualene part of sterol synthesis in peroxisomes. Furthermore, we show that acetyl-CoA derived from peroxisomal -oxidation of very long-chain fatty acids and medium-chain dicarboxylic acids is preferentially channeled to cholesterol synthesis inside the peroxisomes without mixing with the cytoplasmic acetyl-CoA pool.
Materials and methods

Antibodies
The following antibodies against cholesterol biosynthetic enzymes were used: rabbit polyclonal anti-(HMG-CoA) reductase (a gift of P. Edwards, University of California at Los Angeles), anti-MVK (Biardi et al. 1994) , anti-(isopentenyl diphosphate dimethylallyl diphosphate) (IPP) isomerase 1 (Paton et al. 1997; Kovacs et al. 2004a) , and anti-FPP synthase ; mouse monoclonal anti-(HMG-CoA) reductase (a gift of M.S. Brown and J.L. Goldstein, University of Texas Southwestern Medical Center, USA). Antibodies against the following intracellular compartments were used: (1) Peroxisomes: rabbit polyclonal anti-guinea pig catalase, anti-rat acyl-CoA oxidase (AOX) and anti-rat PMP70 (peroxisomal membrane protein 70) (Beier et al. 1988; Lüers et al. 1993 ) (a gift of A. Völkl, University of Heidelberg); sheep polyclonal anti-human catalase (The Binding Site, Birmingham, UK); (2) mitochondria: rabbit polyclonal anti-cytochrome c (Santa Cruz Biotechnology, Santa Cruz, CA); (3) lysosomes and endosomes: mouse monoclonal anti-human Limp-1 (CD63), anti-Rab5 and anti-(early endosome antigen 1) (EEA1) (BD Biosciences-Pharmingen, San Diego, CA); mouse monoclonal anti-human Lamp-2 (lysosomal associated membrane protein-2) (Research Diagnostics, Flanders, NJ). The monoclonal mouse antibody against the myc epitope was obtained from Invitrogen (Carlsbad, CA, USA). Species-speciWc anti-IgG antibodies conjugated to Alexa 488 (A-11008, A-11001), 594 (A-11012, A-11005), and 647 (A-21244, A-21235) were obtained from Molecular Probes (Eugene, OR, USA). The Texas Red dye-conjugated donkey anti-sheep IgG (#713-075-147) was obtained from Jackson ImmunoResearch (West Grove, PA, USA).
Cell culture
HepG2 cells (Aden et al. 1979) , derived from a human hepatoblastoma, were obtained from the American Tissue Culture Collections (Rockville, MD) and grown in Dulbecco's ModiWed Eagle Medium:Ham's F-12 (1:1, v/v) medium supplemented with 10% (v/v) fetal calf serum (FCS). The CHO cell line, CHO-K1, and the peroxisome-deWcient mutant CHO lines , which are all deWcient in Pex2p, were obtained from Dr. Raphael A. Zoeller (Boston University School of Medicine, Boston, MA) and grown in Ham's F-12 medium supplemented with 10% (v/v) fetal calf serum. PEX2-transfected CHO-K1/ pPEX2, ZR-78/pPEX2, ZR-82/pPEX2 and ZR-87/ pPEX2 cells were maintained in the same medium containing 500 g/ml G418. Cells were cultivated at 37°C in a humidiWed atmosphere of 5% CO 2 and 95% air. Cells were grown on collagenized coverslips in media containing 5% lipoprotein-deWcient serum (Intracel, Frederick, MD) for 24 h prior to immunoXuorescence studies using antibodies against endogenous cholesterol 
Vector construction
The construction of expression vectors for full-length acetoacetyl-CoA thiolase (ACAT1) containing a myc epitope tag between the mitochondrial and PTSs (Olivier et al. 2000) , pEGFP-PMVK and pEGFP-PMVK PTS (Olivier et al. 1999 ) has been described before. The expression vector pDsRed2-Peroxi, which encodes a fusion of Discosoma sp. red Xuorescent protein and the PTS1 "SKL", was purchased from Clontech. The vector expressing DsRed2 ending in QKL and EKL was generated by ligating the appropriate insert into the Not I and Pst I digested pDsRed2-Peroxi vector. The insert was generated using the primers 5Ј-caggactcctccctgcagga and 5Ј-cgcggccgctacagcttctgcttgta (for pDsRed2-QKL) and pDsRed2-Peroxi as the PCR template. PCR products were ligated into pCR4-TOPO vector (Invitrogen, Carlsbad, CA) and digested with Not I and Pst I. Subcloning and reading frame were veriWed by both restriction digest and DNA sequencing.
Transfection and immunoXuorescence
Transient transfections were performed using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Cells grown on collagen-coated glass coverslips were Wxed with 4% paraformaldehyde in PBS, pH 7.4, permeabilized with 0.2% Triton X-100 and incubated with primary and secondary antibodies as described (Kovacs et al. 2004b) . Fixed cells labeled with antibodies and/or Xuorescent proteins were optically sectioned into z-stacks, with the pinhole set to 1 Airy unit. Fluorescent dyes were imaged sequentially in frame interlace mode to eliminate cross-talk between the channels. Fluorescence was visualized using a DM-IRBE confocal microscope (Leica, Wetzlar, Germany) and images were processed using TCS-NT software (Leica). A representative optical section is presented for each data set.
Cell permeabilization with digitonin
Cell permeabilization experiments were performed as described by Biardi and Krisans (1996) with a few modiWcations. HepG2 cells were seeded at a density of 3.0 £ 10 6 on 100-mm plates and grown to 50% conXuence. The cells were washed with PBS and transferred to media containing 5% lipoprotein-deWcient serum (Intracel, Frederick, MD) for 72 h prior to the experiment. On the day of the experiment, the cells were washed twice with ice-cold KH buVer (50 mM HEPES, 110 mM KOAc, pH 7.2), transferred to ice and incubated in KHM buVer (20 mM HEPES, 110 mM KOAc, 2 mM MgOAc, pH 7.2) containing various concentrations of digitonin (0, 20, 50, 150, 500 , and 1,000 g/ml). After 5 min, the buVer was collected as supernatant fractions and kept on ice. The cells were washed twice with ice-cold KH buVer and subsequently incubated in KH buVer containing 1,000 g/ml digitonin for 30 min. These latter fractions were referred to as pellet fractions. The activities of phosphoglucose isomerase (PGI), a cytosolic marker enzyme, and catalase, a peroxisomal marker enzyme, were measured as described previously (Kovacs et al. 2001 (Zhang et al. 1994 ). The purity of the synthesized compounds was veriWed by gas chromatography-mass spectrometry (GC-MS) and NMR.
Docosanoic acid was dissolved either in ethanol or in 2.8 mM NaOH containing 10% fatty acid-free bovine serum albumin (faf-BSA). Dodecanedioic acid was dissolved in 1 M NaOH and added to the media containing 5% lipoprotein-deWcient serum. HepG2, CHO-K1, and peroxisome-deWcient CHO cells were incubated with either 0.1 mM and 0.2 mM unlabeled and [1, 2, 3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 4 ]docosanoate or 1, 2, and 3 mM unlabeled and [U-13 C 12 ]dodecanedioate for 24, 48, and 72 h. Media were changed every day. Cells were washed once with ice-cold PBS containing 2 mg/ml faf-BSA and twice with PBS prior to collection. Lipid extracts were saponiWed in KOH-ethanol before extraction of the sterols with petroleum ether. The aqueous phase was acidiWed, and fatty acids were extracted with petroleum ether. Sterols and fatty acids were derivatized with pentaXuorobenzoyl chloride and pentaXuorobenzoyl bromide, respectively. The derivatives were assayed by ammonia negative chemical ionization GC-MS to determine the mass isotopomer distribution (MID) of the compounds (Bederman et al. 2004a, b; Kelleher and Masterson 1992; Lindenthal et al. 2002) . All analyses were run with double or triple injection. Mass isotopomers are designated as M, M1, M2,..., Mi, where i is the number of mass units above that of the unlabeled isotopomers M.
Results
Mass isotopomer spectral analysis of cholesterol synthesis
Until the recent demonstration of peroxisomal -oxidation contributing to acetyl-CoA for malonyl-CoA synthesis, peroxisomal -oxidation has not been considered as a substantial source of acetyl-CoA (Reszko et al. 2004 ). However, little information is available on the fate of peroxisomal acetyl-CoA. It has been shown that peroxisomal enzymes can convert acetyl-CoA (presumably derived from very long-chain fatty acid oxidation) to FPP via HMG-CoA and mevalonate ( Fig. 1) (Weinhofer et al. 2006 ; for review see Kovacs et al. 2002) . FPP leaves the peroxisome, and is converted to cholesterol in the endoplasmic reticulum (Stamellos et al. 1993) . In parallel, cytosolic acetoacetyl-CoA thiolase and HMG-CoA synthase form HMGCoA which, in the ER, is converted to mevalonate (Fig. 1 ). The latter diVuses or is transferred into the peroxisomes and mixes with locally made mevalonate. A related question is whether acetyl-CoA, formed by peroxisomal -oxidation of very long-chain fatty acids is (1) directly channeled to cholesterol synthesis inside the peroxisomes, or (2) mixes with cytosolic acetylCoA transferred from mitochondria via citrate before being used for fatty acid and cholesterol synthesis. At least in the liver, part of the acetyl groups derived from peroxisomal oxidation can be released as free acetate (Bian et al. 2005) ; however, the mechanism of the transfer of peroxisomal acetyl-CoA to the cytosol needs to be further studied.
To resolve the issue of the existence of two parallel pathways leading to mevalonate and the two theories on the compartmentation of cholesterol synthesis, we used new stable isotopic techniques and data computations with ISA (Bederman et al. 2004a, b; Kelleher and Masterson 1992; Lindenthal et al. 2002) . We tested whether acetyl-CoA derived from peroxisomal longchain fatty acid oxidation (1) (2) is partially released from the peroxisomes before it is used in the reactions forming extra-peroxisomal mevalonate (Pathway 2; Fig. 1 ). Experiments with (1) carbon-labeled substrates which label exclusively mitochondrial acetyl-CoA, and (2) deuterated or tritiated water which yield a measurement of total fatty acid and cholesterol synthesis, reveal an equal percent contribution of mitochondrial acetyl-CoA to fatty acid and cholesterol synthesis. Thus, tracers that label exclusively or predominantly acetyl-CoA cannot be used to test for a peroxisomal pathway of cholesterol synthesis. However, very longchain fatty acids and medium-chain dicarboxylates undergo initial -oxidation in peroxisomes Leighton et al. 1989; Bian et al. 2005) , and such fatty acids, labeled on the Wrst carbons, generate highly labeled acetyl-CoA in peroxisomes. We compared the MIDs of fatty acids and sterols in CHO-K1, peroxisome-deWcient CHO (ZR-82, ZR-87), and HepG2 cells incubated with various concentrations of [1,2,3,4-13 C 4 ]docosanoate or [U-13 C 12 ]dodecanedioate for 24, 48, and 72 h. The MIDs of fatty acids and sterols were subjected to ISA to estimate the fractional contribution of the labeled precursor to acetyl-CoA.
The MIDs of lathosterol and cholesterol isolated from CHO-K1 cells incubated with 0.1 mM unlabeled docosanoate (C22:0) or [1, 2, 3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 4 ]docosanoate are shown in Table 2 . Lathosterol is the analyte of choice, because, unlike cholesterol, its pool is small and turns over rapidly (Lindenthal et al. 2002) . It is clear, that in the presence of unlabeled docosanoate, few lathosterol molecules contained one or two 13 C atoms. However, in the presence of [1,2,3,4-13 C 4 ]docosanoate, lathosterol molecules contained up to Wve 13 C atoms, which reXects substantial labeling of acetyl-CoA used for sterol synthesis. In contrast, fatty acids (myristate, palmitate, stearate, and oleate) were not labeled from [1,2,3,4-13 C 4 ]docosanoate (data not shown), indicating that acetyl-CoA derived from peroxisomal -oxidation was not released from peroxisomes and mixing with cytosolic acetyl-CoA transferred from mitochondria.
The above data obtained with [1,2,3,4-13 C 4 ]docosanoate were conWrmed by data from experiments with [U-13 C 12 ]dodecanedioate. The latter also generates highly labeled acetyl-CoA in peroxisomes. As controls, we incubated the cells with 2 mM [1,2-13 C 2 ]acetate and 25 mM [U-13 C 6 ]glucose, which forms mitochondrial [U-13 C 2 ]acetyl-CoA. The labeling ratio (acetyl of sterols)/(acetyl of fatty acids) was 1.04 + 0.09 (n = 6) for [U-13 C 6 ]glucose. In contrast, in the presence of 2 mM [U-13 C 12 ]dodecanedioate for 72 h, the labeling ratio was much greater than 1 (i.e., 1.72 in CHO and 1.30 in HepG2 cells), revealing that acetyl-CoA generated by peroxisomal -oxidation is channeled directly to sterol synthesis inside the peroxisomes. Fractional synthesis of fatty acids and sterols varied from 23 to 95%. However, the elevated sterol to fatty acid ratio for acetylCoA enrichment was maintained under all conditions for [U- 13 C 12 ]dodecanedioate compared to [U-13 C 6 ]glucose. In accordance with the data from Bederman et al. (2004a) obtained in perfused rat livers, MID analysis revealed labeling of both fatty acids and sterols from the same [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]acetyl-CoA pool. Furthermore, the labeling of sterols and fatty acids was barely detectable Reactions between mevalonate and farnesyl diphosphate are assumed to be almost exclusively peroxisomal and functional peroxisomal targeting signals have been identiWed in all of those enzymes. FPP leaves the peroxisomes and is converted to cholesterol in the endoplasmic reticulum (ER). In parallel, cytosolic acetyl-CoA is used by cytosolic acetoacetyl-CoA thiolase and HMG-CoA synthase to form HMG-CoA, which is converted to mevalonate in the ER (Pathway 2). The latter diVuses into the peroxisomes and mixes with locally made mevalonate. In the liver, part of the acetyl groups derived from peroxisomal oxidation are released as free acetate; however, the mechanism of the transfer of peroxisomal acetyl-CoA to the cytosol needs to be further studied. Isotopomer spectral analysis of fatty acids and sterols suggests that acetyl-CoA, formed by peroxisomal -oxidation of very long-chain fatty acids and medium-chain dicarboxylic acids is directly channeled to cholesterol synthesis inside the peroxisomes (Pathway 1) without mixing with cytosolic acetyl-CoA transferred from mitochondria before being used for fatty acid and cholesterol synthesis (Pathway 2) ImmunoXuorescence studies show that pre-squalene cholesterol biosynthetic enzymes are peroxisomal
Acetoacetyl-CoA thiolase
The formation of acetoacetyl-CoA is the Wrst step in cholesterol and ketone body synthesis. AcetoacetylCoA thiolase or acetyl-CoA acetyltransferase (ACAT) activity is found in the cytosol, mitochondria, and peroxisomes of mammalian cells. Olivier et al. (2000) provided evidence for a PTS1 in mitochondrial acetoacetyl-CoA thiolase (ACAT1) and suggested that mitochondrial ACAT1 could be targeted under certain circumstances to peroxisomes via its C-terminal QKL (human) or EKL (mouse, rat).
To investigate the targeting of ACAT1, HepG2 cells were transfected with the expression vector for fulllength rat ACAT1 containing a myc epitope tag between the mitochondrial and PTSs as described before (Olivier et al. 2000) . Thereafter, they were processed for double immunoXuorescence labeling using antibodies against the myc epitope, the peroxisomal markers AOX or peroxisomal membrane protein 70 (PMP70), as well as the mitochondrial marker cytochrome c (Fig. 2a-c) . The full-length ACAT1 displayed a mitochondrial distribution pattern in HepG2 cells (Fig. 2a, c ) that was completely superimposable over that for cytochrome c (data not shown). No colocalization with the punctate peroxisomal pattern for AOX (Fig. 2b, c) or PMP70 (data not shown) was observed. We also co-transfected the expression vector for full-length ACAT1 with pDsRed2-Peroxi (a mammalian expression vector that encodes a fusion of Discosoma sp. red Xuorescent protein and the PTS1-SKL) into HepG2 cells. HepG2 cells were analyzed by direct Xuorescence and immunostaining with antibodies against myc and cytochrome c (Fig. 2d-f) . Again, the immunoXuorescence pattern obtained for ACAT1 was completely superimposable over that for cytochrome c and did not overlap with the Xuorescent punctate pattern of peroxisomes (Fig. 2f) .
Our data suggest that the mitochondrial targeting sequence overrules the PTS1 and that it is unlikely that full-length mitochondrial ACAT1 is targeted to peroxisomes. Similarly, experimental evidence showed that the PTS1 signal is lower in hierarchy compared with N-terminal signals such as the mitochondrial targeting signal if they are present in the same protein (Neuberger et al. 2003b) . Most probably, the binding of mitochondrial transport receptors to the N-terminus leads to an immediate mitochondrial import of the nascent polypeptide prior to binding of peroxisomal import receptors to its C-terminal PTS1. To investigate if the C-terminal tripeptide QKL might be functional as PTS1 signal, a DsRed-fusion protein containing this Cterminal peptide was expressed in HepG2 cells (Fig. 2g-i) . In a functional PTS1 signal, the tripeptide SKL or conserved variants thereof would be suYcient for peroxisomal protein import in several species (Gould et al. 1990 ). DsRed ending in QKL, the C-terminus of human ACAT1, showed a punctate distribution (Fig. 2g ) which was superimposable onto the pattern for the peroxisomal marker enzyme AOX (Fig. 2h ) (for overlay, see Fig. 2i ). Analysis of the carboxy-terminal 12 residues of human ACAT1 with a newly developed PTS1 prediction algorithm (Neuberger et al. 2003b ) assigned human ACAT1 as probable PTS1 signal-containing protein and supported our immunoXuorescence data.
Since our mass ISA data and other biochemical experiments demonstrate peroxisomal acetoacetylCoA formation (Thompson and Krisans 1990; Hovik et al. 1991) , either the distribution of ACAT1 between peroxisomes and mitochondria is regulated by the variable usage of alternative transcription or translation initiation sites or another enzyme is involved in the acetyl-CoA condensation reaction in peroxisomes. Indeed, Antonenkov et al. (2000) puriWed a short chain speciWc thiolase from rat liver peroxisomes that is diVerent from the thiolases involved in the breakdown of straight chain and 2-methyl-branched 3-oxoacylCoAs (thiolase A and B and SCPx) and that also appears to be distinct from ACAT1 and cytosolic acetoacetyl-CoA thiolase (ACAT2). Targeting to the peroxisomal matrix could also happen by "piggybacking" of a thiolase (e.g., ACAT2) with another PTS containing protein.
Dual localization of HMG-CoA reductase
To verify the subcellular localization of HMGCR in human cells, we examined the immunoXuorescence pattern obtained with a monoclonal and a polyclonal HMGCR antibody. HepG2 cells were cultured in medium with lipoprotein-deWcient serum (LPDS) and subsequently subjected to double-immunoXuorescence labeling using antibodies against HMGCR (Fig. 3b, e) and the peroxisomal markers catalase (data not shown) or PMP70 (Fig. 3a, d ). The immunoXuorescence pattern obtained for HMGCR was consistent with ER labeling in all cells. However, in addition to an ER labeling pattern, a number of cells exhibited an unambiguous punctate pattern, which was directly superimposable over that for PMP70 (Fig. 3c, f) and catalase (data not shown). These results indicate that in human cells HMGCR is localized both to the ER and peroxisomes. Although probably all cells contain to some degree HMGCR in peroxisomes, peroxisomal HMGCR staining will be masked in most cells by the strong ER labeling, leading to an underestimation. Keller et al. (1986) showed that less than 5% of the total HMGCR activity is located in the peroxisomes of rat liver under control conditions compared with 20-30% of the HMGCR activity detected in peroxisomes of cholestyramine-treated animals. Since peroxisomal HMGCR seems to be encoded by the same gene as the ER enzyme (Breitling and Krisans 2002) , the Fig. 2 The mitochondrial acetyl-CoA acetyltransferase (ACAT1) contains both an amino-terminal mitochondrial targeting signal and a carboxy-terminal PTS1. a-c HepG2 cells were transfected with full-length rat ACAT1 containing a myc epitope and processed for immunoXuorescence microscopy with antibodies against myc (a), the peroxisomal marker acyl-CoA oxidase (AOX) (b), and the mitochondrial marker cytochrome c. Fulllength rat ACAT1 displayed a mitochondrial distribution in HepG2 cells that was completely superimposable over that for cytochrome c (data not shown). Full-length ACAT1 was not found to co-localize with the punctate peroxisomal pattern for AOX (c). Though a few yellow punctate structures in the overlay image imply a co-localization of ACAT1 and AOX (c), analysis of z-sections showed that they were probably due to the proximity of some peroxisomes to the large mitochondrial structures and thus could not be resolved at the light microscopical level. d-f HepG2 cells were co-transfected with full-length rat ACAT1 containing a myc epitope and pDsRed2-SKL and analyzed after 48 h by direct Xuorescence (e) and immunostaining with antibodies against myc (d) and cytochrome c (f). Note the co-localization of ACAT1 and cytochrome c, whereas ACAT1 did not co-localize with the punctate peroxisomal pattern for DsRed2-SKL (f). g-i HepG2 cells were transfected with a construct coding for DsRed2 containing the C-terminal PTS1 QKL and analyzed after 48 h by direct Xuorescence (h) and immunostaining with an antibody against AOX (g). Note the co-localization of DsRed2 ending in QKL, the C-terminus of human ACAT1, and AOX in peroxisomes, demonstrating the ability of QKL to target to peroxisomes (i). peroxisomal HMGCR activity in mammals is probably due to alternative targeting of the ER enzyme to peroxisomes by an as yet uncharacterized mechanism. Interestingly, Johnson et al. (2003) discovered a novel isoform of HMGCR by using junction microarrays to detect alternative splicing. The novel isoform was present as a mixture with the known isoform in every human tissue tested, with the exception of peripheral leukocytes in which only the novel isoform band was visible. However, the variant protein cannot catalyze the reaction of the known isoform, probably because it lacks a portion of the active site (S. Krisans and W. Kovacs, unpublished data).
Mevalonate kinase
The N-terminus of MVK contains a consensus PTS2 sequence (Table 1 ). This PTS2-containing region of MVK from diVerent organisms is highly conserved (Petriv et al. 2004 ). We investigated the subcellular localization of MVK in HepG2 cells cultured in lipoprotein-deWcient medium and in cells overexpressing rat MVK. We performed immunoXuorescence microscopy with four diVerent MVK antibodies that have been shown to be highly speciWc for immunoblot studies (Biardi et al. 1994) . However, only the aYnity-puriWed polyclonal antibody raised against puriWed MVK protein obtained from rat liver was suitable for immunoXuorescence studies. We were not able to detect any immunolabeling for MVK in untransfected cells. The immunoXuorescence pattern obtained with MVK antibody in HepG2 cells overexpressing MVK (Fig. 4a) is superimposable over that for catalase (Fig. 4b , for overlay see Fig. 4c ). We also co-transfected the plasmid pJ3 -MVK (encoding rat MVK) with pDsRed2-Peroxi into HepG2 cells. Both MVK (Fig. 4d) and the red Xuorescent peroxisomal protein (Fig. 4e) were co-localized in peroxisomes (see overlay Fig. 4f ).
Phosphomevalonate kinase
Olivier et al. (1999) postulated a predominant peroxisomal localization of human PMVK based on expression studies in CHO cells with two green Xuorescent protein (GFP) fusion proteins. One fusion protein was produced by attaching a 600 bp fragment of human PMVK cDNA, containing the putative PTS1, to the carboxyl terminus of GFP (pEGFP-PMVK). The other GFP fusion protein construct was generated similarly; however, the putative PTS1 sequence SRL was removed (pEGFP-PMVK PTS). We transfected HepG2 cells with the same GFP constructs to explore the localization of PMVK in human cells. Transient transfection of pEGFP-PMVK into HepG2 cells resulted in a punctate Xuorescence distribution, indicative of a peroxisomal localization (Fig. 5a, d ). The punctate pattern of EGFP-PMVK was superimposable over that of the peroxisomal marker enzyme catalase (Fig. 5b) and PMP70 ( Fig. 5e ) (see overlays Fig. 5c, f) . The putative PTS1 is required for PMVK localization to the peroxisome, since cells transfected with pEGFP-PMVK PTS showed a diVuse, cytoplasmic Xuorescence (Fig. 5g) , which did not overlap with the Xuorescent punctate pattern of peroxisomes obtained with antibodies against catalase (Fig. 5h , for overlay see Fig. 5i ) or PMP70 (data not shown).
However, in some transfections with pEGFP-PMVK or pEGFP-PMVK PTS the GFP-positive cells displayed a punctate pattern (Fig. 5j) which clearly diVered from the punctate Xuorescence of PMP70 (Fig. 5k) or catalase (data not shown). The punctate Xuorescence did not reXect a mitochondrial localization, as determined by co-localization studies using the mitochondrial marker cytochrome c (data not shown); a lysosomal localization, as determined by co-localization studies using the lysosome markers Limp-1 and Lamp-2 (data not shown); or endosomal localization, as determined by co-localization studies using antibodies to early endosome antigen 1 (EEA1) and Rab5 (data not shown). Interestingly, these observations are similar to those published by Hogenboom et al. (2004b) , who observed a punctate pattern that did not co-localize with the punctate pattern of the peroxisomal catalase or the PMP ALDP (adrenoleukodystrophy protein). Thus, they reached the conclusion that this enzyme was not localized to peroxisomes. We assume that these GFP signals represent aggregates of misfolded protein due to overexpression, since the number of cells displaying this punctate pattern increased with high transfection eYciencies and increasing DNA amounts.
IPP isomerase
Isopentenyl diphosphate dimethylallyl diphosphate (IPP) isomerase 1 (IDI1) contains both a putative carboxy terminal PTS1 and an amino terminal PTS2 (Table 1 ; Paton et al. 1997) . We investigated the subcellular localization of IDI1 in HepG2 cells cultured in lipoprotein-depleted medium by immunoXuorescence microscopy. We performed double labeling using a highly speciWc aYnity-puriWed polyclonal antibody directed against mouse IDI1 (Kovacs et al. 2004a) (Fig. 6a) and a sheep polyclonal antibody against human catalase (Fig. 6b) . The immunoXuorescent labeling of IDI1 showed a punctate distribution which was superimposable onto the pattern for the peroxisomal marker enzyme catalase (Fig. 6c) . (Paton et al. 1997) , whereas human Wbroblasts deWcient in the import of both PTS1 and PTS2 proteins displayed cytosolic labeling when the anti-HA antibody was used (Paton et al. 1997) . Furthermore, transfection of CHO cells with HA-tagged IDI1 lacking the putative PTS1 HRM sequence revealed a cytosolic labeling with the anti-HA antibody (V. Paton, . These data showed that the PTS1 sequence is necessary for the targeting of IDI1 to peroxisomes, and that IDI1 does not use the putative PTS2 for peroxisomal targeting.
FPP synthase
Indirect immunoXuorescence microscopy studies by several groups have shown that FPP synthase is localized in the peroxisomes of various cell lines Olivier et al. 2000; Gupta et al. 1999 ). However, subcellular fractionation studies resulted in a signiWcant release of FPP synthase activity into the cytosolic supernatant Gupta et al. 1999) . ImmunoXuorescence studies of myc-tagged rat FPP synthase demonstrated that FPP synthase utilizes the PTS2 import pathway and requires a PTS2-like sequence found within the amino terminal 20 amino acids for localization (Olivier et al. 2000) . In this study, we investigated the subcellular localization of FPP synthase in CHO and HepG2 cells by immunoXuorescence microscopy (Fig. 7) . ImmunoXuorescence patterns for FPP synthase and catalase were similar in CHO-K1 (Fig. 7a-c) , PEX2-transfected ZR-82 (ZR-82/pPEX2) (Fig. 7g-i) , PEX2-transfected ZR-87 (ZR-87/pPEX2) (data not shown), and HepG2 (Fig. 7j-l) cells. These two enzymes were co-localized in peroxisomes as shown by the superimposed images (Fig. 7c, i,  l) . In peroxisome-deWcient ZR-82 cells, the punctate pattern was no longer observed and immunoXuorescence for catalase and FPP synthase was evenly distributed throughout the cytoplasm (Fig. 7d-f) . A similar pattern was observed with peroxisome-deWcient ZR-78 and ZR-87 cells (data not shown). Peroxisome-deWcient ZR-78, ZR-82, and ZR-87 cells have mutations in PEX2, a gene encoding an integral PMP, resulting in nonfunctional Pex2p. Pex2p is involved in the translocation of peroxisomal matrix proteins following the docking of PTS receptors to the peroxisome membrane.
When these peroxisome-deWcient CHO cells were transfected with rat PEX2 and stably selected with G418, peroxisome assembly was restored as demonstrated by the punctate Xuorescence pattern obtained with antibodies to the peroxisomal matrix proteins catalase (Fig. 7h) or AOX (data not shown). Furthermore, the punctate immunoXuorescence pattern for FPP synthase in PEX2-transfected ZR-82 (ZR-82/ pPEX2) cells (Fig. 7g ) coincided with that of catalase (Fig. 7h , for overlay see Fig. 7i ) or AOX (data not shown), thereby demonstrating the import of FPP synthase into peroxisomes. Taken together, these results clearly show that FPP synthase is a peroxisomal protein, similar to the observations reported previously for various other cell lines.
Digitonin permeabilization studies reveal a similar intracellular distribution as immunoXuorescence studies
In order to reinforce the data obtained by mass ISA of cholesterol synthesis and immunoXuorescence microscopy, digitonin permeabilization of HepG2 cells and subsequent western blot analysis was used to further characterize the subcellular localization of cholesterol biosynthetic enzymes. Digitonin treatment of cells has been reported to reversibly permeabilize the plasma membrane while leaving subcellular organellar membranes intact. Digitonin permeabilizes cells by complexing with cholesterol. Since the membranes of most cell organelles contain lower levels of cholesterol than the plasma membrane, cells lose their cytoplasmic components at lower digitonin concentrations, but the organellar content remains intact. HepG2 cells were exposed to increasing concentrations of digitonin. Subsequently, the selective permeabilization and release of enzymes of cytoplasm or subcellular organelles were demonstrated with activity measurements or immunoblots of distinctive subcellular fractions. The release of 
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the cellular enzyme activity of phosphoglucose isomerase (PGI), a cytosolic marker, and catalase, a peroxisomal marker, were measured (Fig. 8) . Most of the release of cytosolic proteins from the permeabilized cells occurred at digitonin concentrations of 50 and 150 g/ml. Catalase remained latent (i.e., inside the peroxisomes) to a digitonin concentration of 150 g/ml. A release of 50% of the peroxisomal matrix content, a, d, g, j) and catalase (b, e, h, k) in CHO and HepG2 cells. The cells were cultured in medium with 5% LPDS for 24 h and subjected to double-immunoXuorescence labeling using aYnity-puriWed rabbit anti-rat FPP synthase followed by Alexa 488-conjugated secondary antibody and sheep anti-human catalase followed by Texas red-conjugated secondary antibody. including catalase and AOX, into the supernatant fraction only occurred at much higher concentrations of digitonin (500-1,000 g/ml). Immunoblot analysis of the various fractions using the antibodies against IPP isomerase (IDI1) and MVK revealed a similar distribution pattern for the IDI1 and MVK proteins as for catalase and AOX, suggestive for the localization of IDI1 and MVK to peroxisomes (Fig. 8) . A signiWcant amount of FPP synthase was released on permeabilization as demonstrated by immunoblot analysis of fractions obtained from permeabilized cells (Fig. 8) . Our data are in accordance with Gupta et al. (1999) , who also reported that FPP synthase is not retained after permeabilization of rat hepatoma cells with digitonin. However, former immunoXuorescence studies clearly showed that FPP synthase is localized in peroxisomes ( Fig. 7 ; Gupta et al. 1999) . These data show that peroxisomal cholesterol biosynthetic enzymes display markedly diVerent association with this organelle.
Discussion
Protein subcellular localization is a key functional characteristic of proteins. The spatial and temporal regulation of biochemical reactions in eukaryotic cells is achieved by a high degree of compartmentation. This structural diVerentiation facilitates interactions and yet allows the segregation of diVerent biochemical networks. The cholesterol/isoprenoid biosynthetic pathway has been the subject of extensive studies in the previous decades due to the panoply of functions of cholesterol, its metabolites, and its immediate biosynthetic precursors in the proper functioning of cells and organisms and understanding of cholesterol homeostasis and its Wne regulation is utterly essential. There is conclusive evidence for the peroxisomal localization of the pre-squalene segment of the cholesterol biosynthetic pathway in rodents (for review, see Kovacs et al. 2002) . However, the role of peroxisomes in cholesterol biosynthesis in humans has been questioned in recent reports by Waterham and coworkers (Hogenboom et al. 2004a, b, c) . To resolve the conXicting reports concerning the localization of enzymes of cholesterol synthesis, we used immunoXuorescence microscopy, selective permeabilization techniques, and new stable isotope labeling techniques and data computations with ISA.
Our present Wndings obtained by immunoXuorescence and selective digitonin permeabilization experiments clearly show that the pre-squalene segment of the cholesterol biosynthetic pathway is localized to peroxisomes, which contradicts the results from Hogenboom et al (2004a, b, c) . We obtained further proof for the localization of the pre-squalene segment of cholesterol synthesis in peroxisomes by MID analysis of fatty acids and sterols in HepG2 and CHO cells, since acetyl-CoA derived from peroxisomal -oxidation of very long-chain fatty acids and medium-chain dicarboxylic acids was preferentially channeled to cholesterol synthesis inside the peroxisomes. In contrast, fatty acids were not labeled from [1,2,3,4-13 C 4 ]docosanoate or [U-
13
C 12 ]dodecanedioate, indicating that acetyl-CoA derived from peroxisomal -oxidation was not released from peroxisomes and mixing with the cytosolic acetyl-CoA transferred from mitochondria before being used for fatty acid and cholesterol synthesis.
In addition, further proof of the peroxisomal localization of cholesterol biosynthetic enzymes comes from studies by Aboushadi et al. (2000) and Weinhofer et al. (2006) . These studies have demonstrated that HMGCR localized to peroxisomes is more resistant to inhibition by statins, a class of cholesterol-lowering drugs, than ER HMGCR. Weinhofer et al. (2006) Furthermore, recent studies by Antonenkov et al. (2004a, b) indicate that the mammalian peroxisomal membrane allows free access into the particles only to small, water-soluble metabolites, while restricting penetration of more bulky organic molecules, such as cofactors (NAD/H, NADP/H, CoA) and phosphorylated substrates. The permeability properties of the peroxisomal membrane require that the export and import of redox equivalents into and out of peroxisomes, and also the transport of acyl-/acetyl-groups across the membrane occur via shuttle systems. Peroxisomes may possess a separate pool of cofactors that is functionally independent from the corresponding pool of cofactors in the surrounding cytoplasm. Since phosphorylated products of mevalonate are not able to cross freely the peroxisomal membrane, it is likely that the multi-stage conversion of mevalonate to FPP will take place in one compartment. The export of FPP across the peroxisomal membrane would be expected to require peroxisomal membrane transport as has been shown for other compounds (AMP and ATP) bearing negatively charged phosphate groups (Palmieri et al. 2001) . Such a peroxisomal transport system for FPP has not been identiWed yet.
Limitations of the subcellular fractionation approach may contribute to the discrepancy met with subcellular localization studies of cholesterol biosynthetic enzymes. The fragility of peroxisomes under in vitro conditions is well known and the uncertainty surrounding the quality of isolated peroxisomes diminishes the validity of in vitro experiments. Some soluble peroxisomal matrix proteins are known to easily leak from peroxisomes during the isolation of peroxisomes (Alexson et al. 1985; Antonenkov et al. 2004a, b) . Several peroxisomal oxidases (urate oxidase, L--hydroxyacid oxidase and D-amino acid oxidase) also possess no latency in digitonin-permeabilized rat hepatocytes, although this type of treatment is much more protective for peroxisomes than tissue homogenization and fractionation (Verleur and Wanders 1993) . This is also exempliWed by a study from Yoshihara et al. (2001) , which clearly showed by immunolocalization studies that the NADPlinked isocitrate dehydrogenase 1 (IDH1) is a predominantly, if not exclusively, peroxisomal enzyme in rat hepatocytes, whereas subcellular fractionation studies revealed that the enzyme is predominantly cytosolic and only partially peroxisomal.
It should be noted, that the conXicting data that have been published recently on the peroxisomal involvement in the biosynthesis of cholesterol are based on immunolocalization studies using antisera against MVK, PMVK, and MPD (Hogenboom et al. 2004a, b, c) . It must be pointed out that not all antibodies will work equally well in all assays. Cell staining techniques place exceptional demands on antibody speciWcity in order to bind speciWcally to antigens in the presence of high concentrations of other macromolecules. Antibody preparations that are satisfactory for techniques such as immunoblotting may show spurious cross-reactions in cell staining. For example, we performed cell-staining experiments with four diVerent polyclonal antibodies against MVK that have been shown to be highly speciWc for immunoblot studies (Biardi et al. 1994) ; however, only one was suitable for immunoXuorescence studies. Furthermore, signiWcant protein levels of cholesterol biosynthetic enzymes in cells and tissues are only present if the cholesterol biosynthetic pathway is induced due to low cholesterol levels or inhibition by statins. For example, while MVK was clearly detected in the matrix of peroxisomes in the liver from cholestyramine plus mevinolin-treated rats, a treatment that upregulates the cholesterol biosynthetic pathway, no immunolabeling was detected in the livers from control animals (Biardi et al. 1994) . Therefore, great care should be taken with the interpretation of results obtained with immunolocalization studies of cholesterol biosynthetic enzymes on human liver sections.
Recently, several computational methods have been developed with the aim of predicting subcellular and peroxisomal localization of proteins (Emanuelsson et al. 2003; Neuberger et al. 2003a, b; Guda and Subramaniam 2005; Xie et al. 2005 ). The assumption is that conservation of function and localization is correlated and thus a prediction of a protein being peroxisomal is strengthened if also its orthologs in other organisms are predicted to be peroxisomal. Thus, if localization to mammalian peroxisomes has been shown in some species, orthologs in other organisms are also assumed to be peroxisomal. For lack of data on PTS2 proteins, in silico prediction methods focus on proteins carrying the C-terminal PTS1. The isoprenoid biosynthesis pathway contains three enzymes with PTS1 motifs (Table 1) . PMVK and IDI1 were predicted to be peroxisomal in several organisms using the methods described by Emanuelsson et al. (2003) , Neuberger et al. (2003a, b) , Xie et al. (2005) , and Guda and Subramaniam (2005) , and their peroxisomal localization was conWrmed in our study. Furthermore, we also showed that the C-terminal tripeptide QKL of human ACAT1 is a functional PTS1 signal. One of the limitations of the computational methods is its inability to accurately predict proteins localized in multiple locations (e.g., HMGCR, acetoacetyl-CoA thiolase in the cholesterol biosynthetic pathway). However, several peroxisomal proteins that have multiple subcellular localizations have been identiWed, including alanineglyoxylate aminotransferase (Oatey et al. 1996; Oda et al. 2000; Huber et al. 2005) , malonyl-CoA decarboxylase (Sacksteder et al. 1999) , and -methylacyl-CoA racemase (Kotti et al. 2000; Amery et al. 2000) .
In summary, our results clearly show that the Wrst part of cholesterol synthesis from acetyl-CoA to FPP occurs in peroxisomes and refute the hypothesis that peroxisomes are not involved in the biosynthesis of isoprenoids and cholesterol. Furthermore, the importance of peroxisomes for the maintenance of cholesterol homeostasis in vivo has clearly been demonstrated in the peroxisome-deWcient PEX2 knockout mouse model (Kovacs et al. 2004a) . We are at present in the process of a more extensive investigation into the role of acetyl-CoA generated in peroxisomes for fatty acid and sterol synthesis. Since it is diYcult to reconcile the diVerent data regarding the localization of cholesterol biosynthetic enzymes using subcellular fractionation and immunohistochemical techniques, the mass isotopomer distribution analysis in combination with mathematical modeling provides a powerful method for metabolic pathway analysis.
